Michael B. Jebsen
2013
In 2013, Michael B. Jebsen earned a total compensation of $399.9K as President, Chief Financial Officer and Former Interim Chief Executive Officer at Tenax Therapeutics, a 6% decrease compared to previous year.
Compensation breakdown
| Salary | $330,000 |
|---|---|
| Stock Awards | $60,308 |
| Other | $9,600 |
| Total | $399,908 |
Jebsen received $330K in salary, accounting for 83% of the total pay in 2013.
Jebsen also received $60.3K in stock awards and $9.6K in other compensation.
Rankings
In 2013, Michael B. Jebsen's compensation ranked 10,056th out of 12,286 executives tracked by ExecPay. In other words, Jebsen earned more than 18.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,056 out of 12,286 | 18th |
Division Manufacturing | 3,740 out of 4,612 | 19th |
Major group Chemicals And Allied Products | 1,193 out of 1,466 | 19th |
Industry group Drugs | 935 out of 1,160 | 19th |
Industry Pharmaceutical Preparations | 724 out of 890 | 19th |
Source: SEC filing on August 12, 2014.